Korean J Clin Microbiol.
2007 Oct;10(2):143-149.
Drug Susceptibility and Clinical Significance of Rapidly Growing Mycobacteria Isolated from Patients with Non-Tuberculous Mycobacteriosis
- Affiliations
-
- 1Department of Laboratory Medicine, Dong-A University College of Medicine, Busan, Korea.
- 2Department of Laboratory Medicine, Pusan National University School of Medicine, Busan, Korea. CCHL@pusan.ac.kr
- 3Department of Internal Medicine, Ulsan University College of Medicine, Ulsan, Korea.
- 4Department of Laboratory Medicine, Ulsan University College of Medicine, Ulsan, Korea.
- 5Korean Institute of Tuberculosis, The Korean National Tuberculosis Association, Seoul, Korea.
Abstract
-
BACKGROUND: It is recommended that all rapidly growing mycobacteria (RGM) isolated from patients with mycobacteriosis are subjected to antimicrobial susceptibility testing. The current study was aimed to perform susceptibility test on clinical strains of RGM isolated from patients with mycobacteriosis and to determine the clinical significance of the isolates.
METHODS
For 17 patients with RGM infection from 2002 to 2006 at Ulsan University Hospital, medical records were reviewed retrospectively and anti-mycobacterial susceptibility test was performed for the clinical isolates by broth microdilution method.
RESULTS
Rates of susceptible strains of RGMs against individual drugs were as follows: amikacin 100%, cefoxitin 59%, ciprofloxacin 82%, clarithromycin 71%, doxycycline 18%, imipenem 91% (M. fortuitum), sulfamethoxazole 71%, and tobramycin 100% (M. chelonae). Ten of the 17 nontuberculous mycobacteria (NTM) patients had been treated with anti-tuberculosis drugs initially. Anti-tuberculosis drugs were continued in 3 patients and changed to other antimicrobial agents effective to NTM in 4 patients, all of whom were cured. Five of 7 NTM patients who had been treated with anti-NTM treatment were cured. All isolates from the patients treated with anti-NTM drugs were susceptible to at least one of the drugs administered.
CONCLUSION
Clinical isolates of RGMs showed fully susceptible to amikacin, while highly resistant to doxycycline and variable to other drugs depending on the species.
Keyword
MeSH Terms
-
Amikacin
Anti-Infective Agents
Cefoxitin
Ciprofloxacin
Clarithromycin
Doxycycline
Humans
Imipenem
Medical Records
Mycobacterium fortuitum
Nontuberculous Mycobacteria
Retrospective Studies
Sulfamethoxazole
Tobramycin
Ulsan
Amikacin
Anti-Infective Agents
Cefoxitin
Ciprofloxacin
Clarithromycin
Doxycycline
Imipenem
Sulfamethoxazole
Tobramycin
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Studies on Identification and Drug Resistance of Atypical Mycobacteria Isolated from Patients with Pulmonary Tuberculosis
- Clinical Significance and Species Identification of Rapidly Growing Mycobacteria Isolated from Routine Blood Cultures
- Evaluation of the Broth Microdilution Method Using 2,3-Diphenyl-5-thienyl-(2)-tetrazolium Chloride for Rapidly Growing Mycobacteria Susceptibility Testing
- Comparison of Three Egg-based Solid Media for Culture of Mycobacteria from Clinical Specimens
- Studies on the Identification and Clinical Significance of Human- Pathogenic Atypical Mycobacteria
